FDA Approved Dupilumab to Treat Eczema
Dupilumab (Dupixent) was approved by the FDA in 2017 to treat moderate to severe eczema (or atopic dermatitis). “This medicine has been a game-changer for my patients, many of whom have been suffering most of their lives,” says Dr. George. Approximately 30% of children and 10% of adults suffer from eczema. Before this new treatment …